Literature DB >> 34401929

Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer.

Qihang Shang1, Li Fu2, Yizhen Pang1, Tinghua Meng1, Xiurong Wu1, Long Sun1, Haojun Chen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34401929     DOI： 10.1007/s00259-021-05519-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation.

Authors:  K J Mortelé; M Praet; H Van Vlierberghe; M Kunnen; P R Ros
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

Review 2.  Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool.

Authors:  Punit Sharma; Shashank Shekhar Singh; Shankaramurthy Gayana
Journal:  Clin Nucl Med       Date:  2021-03-01       Impact factor: 7.794

3.  [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.

Authors:  Barbara Kreppel; Florian C Gärtner; Milka Marinova; Ulrike Attenberger; Michael Meisenheimer; Marieta Toma; Glen Kristiansen; Georg Feldmann; Euy Sung Moon; Frank Roesch; Pieter Van Der Veken; Markus Essler
Journal:  Nuklearmedizin       Date:  2020-05-11       Impact factor: 1.379

4.  Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules.

Authors:  Ximin Shi; Haiqun Xing; Xiaobo Yang; Fang Li; Shaobo Yao; Hui Zhang; Haitao Zhao; Marcus Hacker; Li Huo; Xiang Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-29       Impact factor: 9.236

5.  Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

Authors:  Haojun Chen; Yizhen Pang; Jingxun Wu; Liang Zhao; Bing Hao; Jing Wu; Jihong Wei; Siming Wu; Long Zhao; Zuoming Luo; Xuehua Lin; Chengrong Xie; Long Sun; Qin Lin; Hua Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-28       Impact factor: 9.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.